NCT00963274 2018-04-23Bortezomib and Romidepsin in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaVirginia Commonwealth UniversityPhase 1 Completed18 enrolled
NCT00114257 2013-02-11Decitabine and FR901228 in Treating Patients With Relapsed or Refractory Leukemia, Myelodysplastic Syndromes, or Myeloproliferative DisordersNational Cancer Institute (NCI)Phase 1 Completed36 enrolled
NCT00024180 2013-01-31FR901228 in Treating Patients With Hematologic CancerNational Cancer Institute (NCI)Phase 1 Completed